Revvity launches SaaS platform to accelerate drug development – ET HealthWorld
Waltham: To foster scientific collaboration between the R&D disciplines of drug discovery to the development of special chemical materials, Revvity, Inc. today announced the launch of its Signal Investigation Packagea unified, cloud-native SaaS platform. The new solution from Revvity Signals Software, the IT and software arm of Revvity, will be available worldwide. The SaaS platform … Read more